Naringenin Attenuates Non-Alcoholic Fatty Liver Disease by Enhancing Energy Expenditure and Regulating Autophagy via AMPK

Background: The prevalence of non-alcoholic fatty liver disease (NAFLD) keeps growing recently. Purpose: To investigate the effects and mechanisms of naringenin (NAR) on NAFLD. Methods: High-fat diet (HFD)-induced NAFLD rats were orally administered with NAR at 10, 30, and 90 mg/kg for 2 weeks. The...

Descripción completa

Detalles Bibliográficos
Autores principales: Yang, Ying, Wu, Yue, Zou, Jie, Wang, Yu-Hao, Xu, Meng-Xia, Huang, Wei, Yu, Dao-Jiang, Zhang, Li, Zhang, Yuan-Yuan, Sun, Xiao-Dong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215389/
https://www.ncbi.nlm.nih.gov/pubmed/34163366
http://dx.doi.org/10.3389/fphar.2021.687095

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215389/
https://www.ncbi.nlm.nih.gov/pubmed/34163366
http://dx.doi.org/10.3389/fphar.2021.687095

Ejemplares similares